Biotech company NTx Bio paused its plans for a $31 million manufacturing facility in Plano, delaying a project that was expected to play a key role in the city’s emerging life sciences ambitions.
The plant, announced in May 2025, was scheduled to open in the first quarter of 2026. At the time of its announcement, the project was positioned as a cornerstone investment in a broader effort to attract life sciences companies to North Texas.
NTx Bio produces pharmaceutical-grade raw materials used in the development of RNA and protein therapeutics. These materials are critical components in modern medicine and are used in treatments for cancer and rare diseases. The company’s work supports a growing sector of the biotech industry focused on advanced therapeutics and precision medicine.
A Key Piece Of A Larger Vision
NTx Bio’s planned facility was part of the Texas Research Quarter, a proposed $4 billion life sciences innovation district envisioned for Plano. The district was intended to cluster research, manufacturing, and corporate partners in one centralized area, anchored by the former Electronic Data Systems campus…